Cigna Group Shares Are On The Rise Friday: What's Going On?

Zinger Key Points

Cigna reported lower-than-expected Q4 earnings due to higher medical costs, causing an initial stock drop before rebounding on Friday.
Despite the earnings miss, revenue grew 27% year-over-year and Cigna increased its share repurchase program by $6 billion.
Get 5 stock picks identified before their biggest breakouts, identified by the same system that spotted Insmed, Sprouts, and Uber before their 20%+ gains.

Cigna Group inc. CI shares are rebounding Friday after dropping on Thursday following a fourth-quarter earnings miss.

What To Know: Cigna reported fourth-quarter revenue of $65.68 billion, exceeding analyst estimates of $63.36 billion, but missed on earnings with an adjusted EPS of $6.64 versus expectations of $7.82. The earnings shortfall was driven by higher stop-loss medical costs, which contributed to an 8% decline in adjusted income from operations.

Despite the earnings miss, revenue grew 27% year-over-year, led by increases in pharmacy benefit services and specialty care. The company also announced a $6 billion increase to its share repurchase program, bringing total authorization to $10.3 billion.

Cigna provided 2025 guidance, expecting at least $252 billion in revenue, slightly above estimates. However, full-year adjusted EPS guidance of at least $29.50 fell short of analysts’ expectations of $31.50.

Shares initially dropped 11.1% on Thursday but are rebounding potentially as investors focus on management's corrective actions and long-term strategy.

CI Price Action: Cigna Group shares were up 4.97% at $297.04 at the time of writing, according to Benzinga Pro.